OTS brings the oligonucleotide community together to exchange ideas, address development challenges, and advance the next generation of therapeutics. This year, Synoligo will join that conversation as a Platinum Sponsor, October 11–14 in Denver.

At OTS, we’ll be highlighting our expanded end-to-end oligonucleotide services, supporting programs from custom synthesis and conjugation through in vitro screening and lead candidate selection.

If you’re navigating a complex program or challenging workflow, visit Booth #34 to discuss how our team can bring each step together through one integrated oligonucleotide solution.

📍 Booth #34

#OTS2026 #OligoTherapeutics #RNATherapeutics #siRNA #ASO #Synoligo